Testosterone and the metabolic syndrome;Testosteron und das metabolische Syndrom

Urologe - Ausgabe A

Volumn 49, Issue 1, 2010, Pages 47-50

  Schubert, M ^a   Jockenhovel F ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Evangelisches Krankenhaus Herne   (Germany)

Author keywords

Metabolic syndrome; Testosterone; Type 2 diabetics

Indexed keywords

ANDROGEN; HIGH DENSITY LIPOPROTEIN; TESTOSTERONE;

ABDOMINAL OBESITY; ANDROGEN THERAPY; BODY FAT; CLINICAL TRIAL; GLYCEMIC CONTROL; HUMAN; LIPID METABOLISM; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSTATE CANCER; SHORT SURVEY;

DIABETES MELLITUS, TYPE 2; HUMANS; MALE; METABOLIC SYNDROME X; TESTOSTERONE;

EID: 77249098649     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-009-2198-7     Document Type: Short Survey

References (21)

1. Blüher M, Stumvoll M (2006) Metabolic syndrome - myths, mechanisms, management. Dtsch Med Wochenschr 131(20):1167-1172
2. Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937-952
3. Grundy SM, Cleeman JI, Daniels SR et al (2005) American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735-2752
4. International Diabetes Federation (2005) Worldwide definition of the metabolic syndrom. http://www.ifd.org/docs/ifd-Metasyndrom-definition.pdf
5. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16(5):442-443
6. McLaughlin T, Abbasi F, Cheal K et al (2003) Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139(10):802-809
7. Simon D, Preziosi P, Barrett-Connor E et al (1992) Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 35(2):173-177
8. Stellato RK, Feldman HA, Hamdy O et al (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23(4):490-494
9. Svartberg J, Midtby M, Bønaa KH et al (2003)The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study. Eur J Endocrinol 149(2):145-152
10. Yeap BB, Chubb SA, Hyde Z et al (2009) Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men. The Health In Men Study. Eur J Endocrinol (Epub ahead of print)
11. Smith JC, Bennett S, Evans LM et al (2001) The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86(9):4261-4267
12. Basaria S, Muller DC, Carducci MA et al (2006) Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106(3):581-588
13. Wang C, Cunningham G, Dobs A et al (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89(5):2085-2098
14. Page ST, Amory JK, Bowman FD et al (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90(3):1502-1510
15. Isidori AM, Giannetta E, Gianfrilli D et al (2005) Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 63(4):381-394
16. Bhasin S, Woodhouse L, Casaburi R et al (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281(6):E1172-E1181
17. Basu R, Dalla Man C, Campioni M et al (2007) Effects of Two Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance and Postprandial Glucose Turnover in Elderly Men. Diabetes Care 30:1972-1978 (Pubitemid 47219403)
18. Lee CH, Kuo SW, Hung YJ et al (2005) The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocr Res 31:139-148
19. Kapoor D, Goodwin E, Channer KS, Jones TH (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154:899-906
20. Heufelder AE, Saad F, Bunck MC, Gooren LJ (2009) 52-Week Treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycaemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl (Epub ahead of print)
21. Zitzmann M, Saad F (2009) Poster P3-307. American Endocrine Society. Chevy Chase, MD, USA